BETH WESLOW: Open Payments
NPI 1528122744 · DERBY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 46 payments from 12 companies in 2025. Trend: 2023 $1,260 · 2024 $1,258 · 2025 $1,120
Food & beverage: $1,120
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $462 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $194 |
| Grifols USA, LLC | 5 | $101 |
| ALK-Abello, Inc | 1 | $62 |
| Exact Sciences Corporation | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Viatris Specialty LLC | 3 | $49 |
| Lilly USA, LLC | 2 | $33 |
| Amphastar Pharmaceuticals, Inc. | 1 | $17 |
Products named: Ozempic, XIFAXAN, Wegovy, Prolastin-C Liquid, Odactra, Cologuard Collection Kit, TRELEGY ELLIPTA, FARXIGA.
Industry payments across NY — which companies pay providers there.
